Skip to main content
Premium Trial:

Request an Annual Quote

Response Biomedical’s Q3 Sales up 14 Percent

NEW YORK (GenomeWeb News) – Response Biomedical today reported that its third-quarter revenues rose 39 percent, while its net loss fell around 14 percent.

The genetic test maker brought in revenues of C$2 million (US$1.9 million) for the three-month period ended Sept. 30, compared to revenues of C$1.5 million in the period last year.

Most of that revenue boost came from the firm’s clinical products business, which increased 62 percent to around C$1.7 million compared with approximately C$1 million a year ago.

The firm’s non-clinical sales slid to C$260,000 from C$331,000 over the same period.

Response Biomedical's net loss for the first quarter was C$3.2 million, or C$.01 per share, compared to a net loss of $3.7 million, or C$.03 per share, for the third quarter of 2008.

The firm said its expenses for the quarter decreased around 15 percent to C$2.8 million from C$3.3 million in the year-ago period, but it did not break out R&D and SG&A spending for the quarter.

Based in Vancouver, BC, Response Biomedical offers the RAMP diagnostic test reader and cartridges and on-site diagnostic tests for clinical and environmental applications.

Response Biomedical finished the quarter with C$7.5 million in cash and cash equivalents.

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.